The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Germline RAD51C mutations confer susceptibility to ovarian cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Breast Cancer Susceptibility Collaboration (UK), Seal, S., Thompson, D., Renwick, A., Elliott, A., Kelly, P., Barfoot, R., Chagtai, T., Jayatilake, H., Ahmed, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1902 · Cited by 746
Self-citationMeindl, A., Hellebrand, H., Wiek, C., Erven, V., Wappenschmidt, B., Niederacher, D., Freund, M., Lichtner, P., Hartmann, L., Schaal, H., et al. (2010) · Nature Genetics · doi:10.1038/ng.569 · Cited by 743
Germline mutations in RAD51D confer susceptibility to ovarian cancer
Breast Cancer Susceptibility Collaboration (UK), Loveday, C., Turnbull, C., Ramsay, E., Hughes, D., Ruark, E., Frankum, J. R., Bowden, G., Kalmyrzaev, B., Warren-Perry, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.893 · Cited by 534
Self-citationATM and breast cancer susceptibility
Ahmed, M., & Rahman, N. (2006) · Oncogene · doi:10.1038/sj.onc.1209873 · Cited by 216
Self-citationRAD51C is a susceptibility gene for ovarian cancer
Pelttari, L. M., Heikkinen, T., Thompson, D. J., Kallioniemi, A. H., Schleutker, J., Holli, K., BLOMQVIST, C. P., Aittomäki, K., Bützow, R. C., & Nevanlinna, H. A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr229 · Cited by 142
Wong‐Brown, M. W., Nordfors, C., Mossman, D., Pecenpetelovska, G., Avery‐Kiejda, K. A., Talseth‐Palmer, B. A., Bowden, N. A., & Scott, R. J. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1443-0 · Cited by 105
Thompson, E. R., Boyle, S. E., Johnson, J., Ryland, G. L., Sawyer, S. D., Choong, D. Y. H., kConFab, Chenevix‐Trench, G., Trainer, A. H., Lindeman, G. J., et al. (2011) · Human Mutation · doi:10.1002/humu.21625 · Cited by 84
RAD51C Germline Mutations in Breast and Ovarian Cancer Cases from High-Risk Families
Clague, J., Wilhoite, G., Adamson, A. W., Bailis, A. M., Weitzel, J. N., & Neuhausen, S. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025632 · Cited by 71
Fanconi anemia and breast cancer susceptibility meet again
Levy‐Lahad, E. (2010) · Nature Genetics · doi:10.1038/ng0510-368 · Cited by 64
Vuorela, M., Pylkäs, K., Hartikainen, J. M., Sundfeldt, K., Lindblom, A., von Wachenfeldt, A., Haanpää, M. K., Puistola, U., Rosengren, A., Anttila, M., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1677-x · Cited by 60
Cited by
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
Bowtell, D. D., Böhm, S., Ahmed, A. A., Aspuria, P.-J., Bast, R. C., Beral, V., Berek, J. S., Birrer, M. J., Blagden, S., Bookman, M. A., et al. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4019 · Cited by 1,367
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Easton, D. F., Pharoah, P. D. P., Antoniou, A. C., Tischkowitz, M., Tavtigian, S. V., Nathanson, K. L., Devilee, P., Meindl, A., Couch, F. J., Southey, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1501341 · Cited by 920
Self-citationHomologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins
Prakash, R., Zhang, Y., Feng, W., & Jasin, M. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016600 · Cited by 869
Inherited Mutations in Women With Ovarian Carcinoma
Norquist, B. M., Harrell, M. I., Brady, M. F., Walsh, T., Lee, M. K., Gulsuner, S., Bernards, S. S., Casadei, S., Yi, Q., Burger, R. A., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5495 · Cited by 769
Polak, P., Kim, J., Braunstein, L. Z., Karlic, R., Haradhavala, N. J., Tiao, G., Rosebrock, D., Livitz, D., Kübler, K., Mouw, K. W., et al. (2017) · Nature Genetics · doi:10.1038/ng.3934 · Cited by 531
Metadata
- Authors
- Breast Cancer Susceptibility Collaboration (BCSC) (UK), Loveday, C., Turnbull, C., Ruark, E., Xicola, R. M. M., Ramsay, E., Hughes, D., Warren-Perry, M., Snape, K., Eccles, D., Evans, D. G., Gore, M., Renwick, A., Seal, S., Antoniou, A. C., & Rahman, N.
- Venue
- Nature Genetics
- Published
- 2012-04-26
- Volume
- 44
- Issue
- 5
- Pages
- 475-476
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1994948218
- Cited by
- 252
- References
- 14
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Germline RAD51C mutations confer susceptibility to ovarian cancer. https://app.cochat.ai/papers/10.1038/ng.2224
- The paper
- Breast Cancer Susceptibility Collaboration (BCSC) (UK), Loveday, C., Turnbull, C., Ruark, E., Xicola, R. M. M., Ramsay, E., Hughes, D., Warren-Perry, M., Snape, K., Eccles, D., Evans, D. G., Gore, M., Renwick, A., Seal, S., Antoniou, A. C., & Rahman, N. (2012). Germline RAD51C mutations confer susceptibility to ovarian cancer. Nature Genetics. https://doi.org/10.1038/ng.2224
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.